Bruton Tyrosine Kinase Inhibitors for Chronic Lymphocytic Leukemia | Jennifer R Brown MD, PhD

Name: Bruton Tyrosine Kinase Inhibitors for Chronic Lymphocytic Leukemia | Jennifer R Brown MD, PhD
Uploaded: 2026-05-24T03:53:00+0000
Duration: 1736 s
Description: Year in Review: Clinical Investigator Perspectives on the Most Relevant New Datasets and Advances in Bruton Tyrosine Kinase Inhibitors for Chronic Lymphocytic Leukemia | Faculty Presentation 2: Emerging BTK Inhibitor-Based Combination Approaches in CLL — Jennifer R Brown MD, PhD CME information and

Posted on 05/24/2026

28:56 |

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Datasets and Advances in Bruton Tyrosine Kinase Inhibitors for Chronic Lymphocytic Leukemia | Faculty Presentation 2: Emerging BTK Inhibitor-Based Combination Approaches in CLL — Jennifer R Brown MD, PhD

CME information and select publications